Does the media refer more to DH or EVH?

In the previous week, Evolent Health had 1 more articles in the media than Definitive Healthcare. MarketBeat recorded 2 mentions for Evolent Health and 1 mentions for Definitive Healthcare. Evolent Health's average media sentiment score of 0.25 beat Definitive Healthcare's score of 0.00 indicating that Evolent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definitive Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Evolent Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CTEV or DH?

In the previous week, Claritev and Claritev both had 1 articles in the media. Claritev's average media sentiment score of 0.00 equaled Definitive Healthcare'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Claritev 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Definitive Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer DH or ONMD?

Definitive Healthcare presently has a consensus price target of $1.47, indicating a potential upside of 57.66%. Given Definitive Healthcare's stronger consensus rating and higher possible upside, equities analysts clearly believe Definitive Healthcare is more favorable than OneMedNet. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Definitive Healthcare 3 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 1.90 OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer DH or ONMD?

In the previous week, OneMedNet had 3 more articles in the media than Definitive Healthcare. MarketBeat recorded 4 mentions for OneMedNet and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.00 beat OneMedNet's score of -0.50 indicating that Definitive Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definitive Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OneMedNet 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Does the media favor OPRX or DH?

In the previous week, OptimizeRx had 3 more articles in the media than Definitive Healthcare. MarketBeat recorded 4 mentions for OptimizeRx and 1 mentions for Definitive Healthcare. OptimizeRx's average media sentiment score of 0.25 beat Definitive Healthcare's score of 0.00 indicating that OptimizeRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Definitive Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Definitive Healthcare (DH) Competitors

$0.93 0.00 (0.00%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$0.94 +0.00 (+0.18%)

As of 10/2/2026 07:30 PM Eastern

Compare

DH vs. EVH, CTEV, ONMD, AMWL, and OPRX

Should you buy Definitive Healthcare stock or one of its competitors? Definitive Healthcare's main competitors and comparable companies include Evolent Health (EVH), Claritev (CTEV), OneMedNet (ONMD), American Well (AMWL), and OptimizeRx (OPRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Definitive Healthcare compare to Evolent Health?

Definitive Healthcare (NASDAQ:DH) and Evolent Health (NYSE:EVH) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Definitive Healthcare presently has a consensus price target of $1.47, indicating a potential upside of 57.66%. Evolent Health has a consensus price target of $5.96, indicating a potential upside of 71.68%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts clearly believe Evolent Health is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63

98.7% of Definitive Healthcare shares are held by institutional investors. 17.1% of Definitive Healthcare shares are held by company insiders. Comparatively, 1.5% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Definitive Healthcare has higher earnings, but lower revenue than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.41	-$138.93M	-$1.60	N/A
Evolent Health	$1.88B	0.21	-$534.51M	-$4.57	N/A

In the previous week, Evolent Health had 1 more articles in the media than Definitive Healthcare. MarketBeat recorded 2 mentions for Evolent Health and 1 mentions for Definitive Healthcare. Evolent Health's average media sentiment score of 0.25 beat Definitive Healthcare's score of 0.00 indicating that Evolent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definitive Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Evolent Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Definitive Healthcare has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market. Comparatively, Evolent Health has a beta of 1.02, indicating that its share price is 2% more volatile than the broader market.

Evolent Health has a net margin of -24.08% compared to Definitive Healthcare's net margin of -72.28%. Definitive Healthcare's return on equity of 3.55% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
Evolent Health	-24.08%	-4.27%	-1.06%

Summary

Definitive Healthcare beats Evolent Health on 10 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to Claritev?

Claritev (NYSE:CTEV) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

Claritev has a net margin of -28.46% compared to Definitive Healthcare's net margin of -72.28%. Definitive Healthcare's return on equity of 3.55% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Claritev	-28.46%	N/A	-5.76%
Definitive Healthcare	-72.28%	3.55%	1.63%

Claritev has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market.

Definitive Healthcare has lower revenue, but higher earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Claritev	$965.41M	0.42	-$284.28M	-$17.01	N/A
Definitive Healthcare	$241.52M	0.41	-$138.93M	-$1.60	N/A

87.2% of Claritev shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 7.4% of Claritev shares are owned by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Claritev currently has a consensus price target of $44.83, suggesting a potential upside of 88.77%. Definitive Healthcare has a consensus price target of $1.47, suggesting a potential upside of 57.66%. Given Claritev's stronger consensus rating and higher probable upside, equities analysts clearly believe Claritev is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Claritev	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90

In the previous week, Claritev and Claritev both had 1 articles in the media. Claritev's average media sentiment score of 0.00 equaled Definitive Healthcare'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Claritev	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Definitive Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Definitive Healthcare beats Claritev on 9 of the 15 factors compared between the two stocks.

How does Definitive Healthcare compare to OneMedNet?

Definitive Healthcare (NASDAQ:DH) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends.

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 1.0% of OneMedNet shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 50.2% of OneMedNet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, OneMedNet had 3 more articles in the media than Definitive Healthcare. MarketBeat recorded 4 mentions for OneMedNet and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.00 beat OneMedNet's score of -0.50 indicating that Definitive Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definitive Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OneMedNet	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Definitive Healthcare has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.14, indicating that its share price is 14% more volatile than the broader market.

Definitive Healthcare presently has a consensus price target of $1.47, indicating a potential upside of 57.66%. Given Definitive Healthcare's stronger consensus rating and higher possible upside, equities analysts clearly believe Definitive Healthcare is more favorable than OneMedNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Definitive Healthcare has a net margin of -72.28% compared to OneMedNet's net margin of -584.20%. Definitive Healthcare's return on equity of 3.55% beat OneMedNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
OneMedNet	-584.20%	N/A	-521.20%

OneMedNet has lower revenue, but higher earnings than Definitive Healthcare. OneMedNet is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.41	-$138.93M	-$1.60	N/A
OneMedNet	$1.36M	23.50	-$2.80M	-$1.60	N/A

Summary

Definitive Healthcare beats OneMedNet on 11 of the 15 factors compared between the two stocks.

How does Definitive Healthcare compare to American Well?

Definitive Healthcare (NASDAQ:DH) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

Definitive Healthcare presently has a consensus price target of $1.47, indicating a potential upside of 57.66%. American Well has a consensus price target of $9.50, indicating a potential downside of 22.80%. Given Definitive Healthcare's higher possible upside, analysts clearly believe Definitive Healthcare is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

American Well has a net margin of -35.75% compared to Definitive Healthcare's net margin of -72.28%. Definitive Healthcare's return on equity of 3.55% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
American Well	-35.75%	-30.12%	-22.30%

In the previous week, Definitive Healthcare had 1 more articles in the media than American Well. MarketBeat recorded 1 mentions for Definitive Healthcare and 0 mentions for American Well. Definitive Healthcare's average media sentiment score of 0.00 equaled American Well'saverage media sentiment score.

Company	Overall Sentiment
Definitive Healthcare	Neutral
American Well	Neutral

American Well has higher revenue and earnings than Definitive Healthcare. American Well is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.41	-$138.93M	-$1.60	N/A
American Well	$249.32M	0.82	-$95.70M	-$4.77	N/A

Definitive Healthcare has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market. Comparatively, American Well has a beta of 1.67, meaning that its share price is 67% more volatile than the broader market.

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 12.8% of American Well shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Definitive Healthcare beats American Well on 9 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to OptimizeRx?

OptimizeRx (NASDAQ:OPRX) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

OptimizeRx has a net margin of 4.66% compared to Definitive Healthcare's net margin of -72.28%. OptimizeRx's return on equity of 9.44% beat Definitive Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
Definitive Healthcare	-72.28%	3.55%	1.63%

OptimizeRx has higher earnings, but lower revenue than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43M	1.48	$5.13M	$0.23	37.26
Definitive Healthcare	$241.52M	0.41	-$138.93M	-$1.60	N/A

OptimizeRx has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market.

76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 7.5% of OptimizeRx shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

OptimizeRx presently has a consensus price target of $11.57, suggesting a potential upside of 35.02%. Definitive Healthcare has a consensus price target of $1.47, suggesting a potential upside of 57.66%. Given Definitive Healthcare's higher probable upside, analysts clearly believe Definitive Healthcare is more favorable than OptimizeRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90

In the previous week, OptimizeRx had 3 more articles in the media than Definitive Healthcare. MarketBeat recorded 4 mentions for OptimizeRx and 1 mentions for Definitive Healthcare. OptimizeRx's average media sentiment score of 0.25 beat Definitive Healthcare's score of 0.00 indicating that OptimizeRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Definitive Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

OptimizeRx beats Definitive Healthcare on 11 of the 17 factors compared between the two stocks.

Get Definitive Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DH vs. The Competition

Export

Metric	Definitive Healthcare	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$99.63M	$1.74B	$7.16B	$13.28B
Dividend Yield	N/A	3.97%	2.53%	17.33%
P/E Ratio	-0.58	20.33	274.69	26.04
Price / Sales	0.41	87.60	610.13	91.98
Price / Cash	0.47	31.81	27.22	34.69
Price / Book	0.35	6.17	10.97	6.34
Net Income	-$138.93M	-$18.66M	$3.50B	$381.73M
7 Day Performance	1.97%	-1.70%	-1.84%	-0.72%
1 Month Performance	-11.11%	-1.33%	-6.21%	-4.68%
1 Year Performance	-72.71%	-21.68%	8.03%	1.57%

Definitive Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DH Definitive Healthcare	2.8436 of 5 stars	$0.93 flat	$1.47 +57.7%	-72.7%	$99.63M	$241.52M	N/A	686
EVH Evolent Health	3.5586 of 5 stars	$3.51 -3.8%	$5.96 +69.8%	-57.6%	$395.15M	$1.88B	N/A	4,200	Analyst Upgrade
CTEV Claritev	2.4083 of 5 stars	$21.71 -3.4%	$44.83 +106.5%	-53.5%	$367.98M	$965.41M	N/A	3,000
ONMD OneMedNet	0.6582 of 5 stars	$5.36 -15.3%	N/A	-47.7%	$329.06M	$1.36M	N/A	2
AMWL American Well	1.4231 of 5 stars	$13.14 -2.3%	$9.50 -27.7%	+94.1%	$219.29M	$249.32M	N/A	562	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DH) was last updated on 10/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Definitive Healthcare (DH) Competitors

DH vs. EVH, CTEV, ONMD, AMWL, and OPRX

How does Definitive Healthcare compare to Evolent Health?

Summary

How does Definitive Healthcare compare to Claritev?

Summary

How does Definitive Healthcare compare to OneMedNet?

Summary

How does Definitive Healthcare compare to American Well?

Summary

How does Definitive Healthcare compare to OptimizeRx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Definitive Healthcare (DH) Competitors

DH vs. EVH, CTEV, ONMD, AMWL, and OPRX

How does Definitive Healthcare compare to Evolent Health?

Do analysts rate DH or EVH?

Do institutionals and insiders believe in DH or EVH?

Which has better valuation & earnings, DH or EVH?

Does the media refer more to DH or EVH?

Which has more volatility and risk, DH or EVH?

Is DH or EVH more profitable?

Summary

How does Definitive Healthcare compare to Claritev?

Is CTEV or DH more profitable?

Which has more risk and volatility, CTEV or DH?

Which has preferable earnings and valuation, CTEV or DH?

Do insiders and institutionals hold more shares of CTEV or DH?

Do analysts prefer CTEV or DH?

Does the media refer more to CTEV or DH?

Summary

How does Definitive Healthcare compare to OneMedNet?

Do institutionals and insiders believe in DH or ONMD?

Does the media prefer DH or ONMD?

Which has more risk & volatility, DH or ONMD?

Do analysts prefer DH or ONMD?

Is DH or ONMD more profitable?

Which has preferable valuation & earnings, DH or ONMD?

Summary

How does Definitive Healthcare compare to American Well?

Do analysts rate DH or AMWL?

Is DH or AMWL more profitable?

Does the media prefer DH or AMWL?

Which has stronger earnings & valuation, DH or AMWL?

Which has more risk & volatility, DH or AMWL?

Do insiders and institutionals have more ownership in DH or AMWL?

Summary

How does Definitive Healthcare compare to OptimizeRx?

Is OPRX or DH more profitable?

Which has higher valuation and earnings, OPRX or DH?

Which has more volatility and risk, OPRX or DH?

Do institutionals and insiders believe in OPRX or DH?

Do analysts rate OPRX or DH?

Does the media favor OPRX or DH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools